Canada’s Allied Corp. claims it has shipped the world’s largest known (legal) cannabis export to date.
Founded by Calum Hughes, PhD, Allied Corp. delivers a variety of cannabis formulations and products for health and wellness. The company’s wholly owned subsidiary in Colombia is a licensed producer of cannabis for medical, research and industrial applications.
The firm kicked off export of dried cannabis from Colombia in June this year – a modest 272kg. That was followed by another shipment of 200kgs in July, then 1,728kgs in August (which went to Switzerland). The latest shipment was a whopping 3,425kgs, which also occurred in August.
“The logistics management that it took to get over 7500 pounds of cannabis approved for export and onto a plane was no easy feat,” said Mr. Hughes.
Mr. Hughes says the company has already shipped over one third of the volume that Canada’s entire cannabis sector exported in 2020.
“We are continuing to scale as each month passes particularly as we enter our high THC harvest within the month of September,” he said.
Among the stated advantages of having medicinal cannabis operations in Colombia, the firm lists:
- A more welcoming and pro-cannabis regulatory environment
- Agricultural infrastructure rivalling that of the US and Canada
- Lower management and operating costs
On the latter, Allied says its cost of production in Colombia is as low as 10 to 15 cents per gram; compared to $1.50 to $2.00 per gram cost of production in Canada.
And then there are the natural attributes:
“Colombia offers the most suitable environment to grow cannabis at scale, ensuring consistently high volume, excellent quality and efficient productivity,” says Allied. The company states it has registered a seed bank in excess of 3,000 indigenous seed varieties and 167 hybrids from around the world.
In addition to its Colombia operations, Allied has three CBD brands on the market in the United States. Allied also has a cultivation facility in Nevada, USA “with a purposeful vision to be ready for US legalization”.
The company says it also has cannabis products in the pharmaceutical development track seeking drug indications for depression, anxiety and PTSD.